Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles
Vanesa G. Martínez(Trinity College Dublin), Lorraine O’Driscoll(Trinity College Dublin)
Cited by 136
Related Papers
Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies
|Obesity Reviews|2014|1.6k
Three-dimensional cell culture: the missing link in drug discovery
|Drug Discovery Today|2012|1.3k
miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer
|Molecular Cancer|2014|77
Neuromedin U alters bioenergetics and expands the cancer stem cell phenotype in HER2‐positive breast cancer
|International Journal of Cancer|2017|38